tradingkey.logo
tradingkey.logo
検索

Bio Rad Laboratories Inc

BIO
ウォッチリストに追加
293.130USD
-2.170-0.73%
取引時間 ET15分遅れの株価
7.86B時価総額
48.61直近12ヶ月PER

詳細情報 Bio Rad Laboratories Inc 企業名

Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. It operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.

Bio Rad Laboratories Incの企業情報

企業コードBIO
会社名Bio Rad Laboratories Inc
上場日Mar 17, 1980
最高経営責任者「CEO」Schwartz (Norman D)
従業員数7700
証券種類Ordinary Share
決算期末Mar 17
本社所在地1000 Alfred Nobel Dr
都市HERCULES
証券取引所NASDAQ OMX NASDAQ Basic NYSE
United States of America
郵便番号94547
電話番号15107247000
ウェブサイトhttps://www.bio-rad.com/
企業コードBIO
上場日Mar 17, 1980
最高経営責任者「CEO」Schwartz (Norman D)

Bio Rad Laboratories Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Norman D. Schwartz
Mr. Norman D. Schwartz
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.38M
-1.00%
Ms. Colleen Corey
Ms. Colleen Corey
Executive Vice President, Global Human Resources
Executive Vice President, Global Human Resources
19.55K
+5.48%
Mr. Sedat Evran
Mr. Sedat Evran
Executive Vice President - Global Supply Chain
Executive Vice President - Global Supply Chain
2.02K
+35.01%
Mr. Gregory K. (Greg) Hinckley, CPA
Mr. Gregory K. (Greg) Hinckley, CPA
Lead Independent Director
Lead Independent Director
1.22K
+33.50%
Ms. Courtney C Enloe
Ms. Courtney C Enloe
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
721.00
+15.12%
Mr. Jeffrey L. (Jeff) Edwards
Mr. Jeffrey L. (Jeff) Edwards
Independent Director
Independent Director
715.00
+56.92%
Mr. Arnold A. Pinkston
Mr. Arnold A. Pinkston
Independent Director
Independent Director
715.00
+56.92%
Ms. Eva Anette Engelhardt
Ms. Eva Anette Engelhardt
Executive Vice President, President of Clinical Diagnostics Group
Executive Vice President, President of Clinical Diagnostics Group
346.00
-158.96%
Ms. Melinda Litherland
Ms. Melinda Litherland
Independent Director
Independent Director
308.00
--
Rajat Mehta
Rajat Mehta
Executive Vice President - Global Commercial Operations
Executive Vice President - Global Commercial Operations
58.00
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Norman D. Schwartz
Mr. Norman D. Schwartz
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.38M
-1.00%
Ms. Colleen Corey
Ms. Colleen Corey
Executive Vice President, Global Human Resources
Executive Vice President, Global Human Resources
19.55K
+5.48%
Mr. Sedat Evran
Mr. Sedat Evran
Executive Vice President - Global Supply Chain
Executive Vice President - Global Supply Chain
2.02K
+35.01%
Mr. Gregory K. (Greg) Hinckley, CPA
Mr. Gregory K. (Greg) Hinckley, CPA
Lead Independent Director
Lead Independent Director
1.22K
+33.50%
Ms. Courtney C Enloe
Ms. Courtney C Enloe
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
721.00
+15.12%
Mr. Jeffrey L. (Jeff) Edwards
Mr. Jeffrey L. (Jeff) Edwards
Independent Director
Independent Director
715.00
+56.92%

よくある質問

Bio Rad Laboratories Incの上位5名の株主は誰ですか?

Bio Rad Laboratories Incの上位5名の株主は以下のとおりです。Mr. Norman D. Schwartz

Bio Rad Laboratories Inc(BIO)の株式を保有している機関の数はいくつですか?

2026Q1時点で、Bio Rad Laboratories Incの株式を保有している機関は1041社あり、保有株式の総市場価値は約18.42Mで、全体の84.86%を占めています。2025Q4と比較して、機関の持ち株は-4188613.00増加しています。
KeyAI